LMF Acquisition Opportunities Inc.
LMAOW
NASDAQ Capital Market0.11
USD
-0.01
- -
CIK
0001831868
ISIN
CA09000L1040
CUSIP
09000L104
Return %
Stock
S&P500
1Y
-58.35
18.21
3Y
-72.50
64.38
5Y
-72.50
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Bruce Martin Rodgers
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1200 West Platt Street Tampa FL United States of America
- IPO Date
- Mar 18, 2021
- CIK
- 0001831868
- Similar Companies
- Business
- LMF Acquisition Opportunities Inc. LMF Acquisition Opportunities Inc. is a blank check company, or special purpose acquisition company (SPAC), formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, with an initial focus on the financial services industry, including financial technology and related sectors; it offers no current products or services beyond its SPAC structure, which includes redeemable warrants such as those traded under the ticker LMAOW exercisable at $11.50 per share until January 26, 2026. Incorporated in 2020 as a Delaware corporation, the company is headquartered at 1200 West Platt Street, Suite 100, Tampa, Florida. LMF Acquisition Opportunities Inc. completed its initial public offering in January 2021, raising $103.5 million through 10.35 million units at $10 each on Nasdaq; in April 2022, it entered a merger agreement with SeaStar Medical, Inc., a medical technology company developing extracorporeal therapies to mitigate hyperinflammation effects on vital organs, which closed via reverse merger on October 28, 2022, resulting in LMF Acquisition Opportunities Inc. being renamed SeaStar Medical Holding Corporation (Nasdaq: ICU), with LMAOW warrants continuing to trade separately post-merger; no further major acquisitions, funding rounds, or strategic shifts have been reported since the 2022 transaction, and the warrants maintain low trading volume and no institutional ownership as of late 2025.